Furthermore, blockage of SPHK1 and/or SPHK2 using different small molecule inhibitors, such as SKI-I, SKI-II, and ABC294640 resulted in synergistic cell death of Ph+ ALL cell lines when combined with imatinib. Here, SPHK1 is linked to acute lymphoblastic leukemia.